Horizon Therapeutics Publ... (HZNP)
NASDAQ: HZNP
· Real-Time Price · USD
116.30
0.00 (0.00%)
At close: Jan 16, 2025, 10:00 PM
Horizon Therapeutics Public Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 438M | 371.9M | 521.48M | 574.26M | 764.96M | 862.1M | 534.49M | 551.87M | 518.16M | 280.04M |
Depreciation & Amortization | 389M | 390.14M | 390.39M | 388.15M | 383.55M | 378.04M | 353.75M | 326.76M | 302.79M | 284.53M |
Stock-Based Compensation | 208.04M | 192.92M | 182.1M | 186.21M | 195.94M | 205.22M | 219.09M | 203.19M | 178.74M | 151.37M |
Other Working Capital | -58.54M | -75.13M | -146.88M | -106.14M | -32.45M | 32.23M | -85.61M | -23.29M | -164.57M | -120.57M |
Other Non-Cash Items | 50.03M | 122.3M | 126.03M | 116.58M | 105.68M | 87.76M | 90.7M | 85.58M | 98.35M | 121.27M |
Deferred Income Tax | -39.11M | -3.6M | 49.81M | 55.57M | -85.93M | -106.14M | -101.02M | -173.35M | -47.01M | -60.14M |
Change in Working Capital | -5.32M | 54.7M | -11.98M | 49.23M | 50.38M | -172.2M | -61.74M | -87.51M | -446.68M | -162.51M |
Operating Cash Flow | 1.04B | 1.13B | 1.26B | 1.37B | 1.41B | 1.25B | 1.04B | 906.53M | 604.35M | 614.55M |
Capital Expenditures | -134.52M | -126.21M | -126.28M | -99.14M | -143.26M | -147.03M | -126.17M | -172.65M | -112.14M | -99.18M |
Cash Acquisitions | 28.45M | 30.48M | 27.35M | -3.1M | -71.04M | -141.04M | -2.85B | -2.84B | -2.78B | -2.86B |
Purchase of Investments | -8.57M | -13.46M | -10.83M | -23.52M | -23.53M | -20.86M | -24.67M | -14.17M | -20.89M | -17.12M |
Sales Maturities Of Investments | 217K | 4.63M | 4.63M | 4.42M | 4.42M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -28.45M | -30.48M | -28.88M | -3.5M | -48M | -45.98M | -47.57M | -69.1M | -24.6M | -24.6M |
Investing Cash Flow | -142.87M | -135.03M | -134M | -121.77M | -231.85M | -305.34M | -2.99B | -3.02B | -2.9B | -2.98B |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -250.08M | -250.08M | -250.08M | -88.21M | n/a | n/a | n/a | -209K | -209K | -209K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -334.43M | -326.05M | -347.96M | -177.28M | -91.16M | -109.11M | 1.47B | 1.46B | 2.39B | 2.41B |
Financial Cash Flow | -334.43M | -326.05M | -347.96M | -177.28M | -91.16M | -109.11M | 1.47B | 1.46B | 2.39B | 2.41B |
Net Cash Flow | 572.11M | 669.13M | 773.43M | 1.06B | 1.08B | 831.82M | -499.32M | -656.59M | 94.47M | 57.19M |
Free Cash Flow | 906.13M | 1B | 1.13B | 1.27B | 1.27B | 1.11B | 909.1M | 733.88M | 492.22M | 515.37M |